Paulin Sonon

Paulin Sonon

Auto-generated profile, based on publicly available information

Paulin Sonon

Laboratório de Imunogenética, Departamento de Imunologia do Instituto Aggeu Magalhães-Fiocruz, Av. Moraes rego, s/n, Campus da UFPE, Cidade Universitária, 50740-465 Recife, PE, Brazil

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2018 in HLA
Verified
Journal Article
Closed access
PDF file
ASA. Sabbagh
A. Sabbagh
PSP. Sonon
P. Sonon
ISI. Sadissou
I. Sadissou
CMCelso Teixeira Mendes-Junior
Celso Teixeira Mendes-Junior
AGAndre Garcia
Andre Garcia
DCD. Courtin
D. Courtin

11 June 2019 in Malaria Journal
Verified
Journal Article
Open access
PDF file
RARafiou Adamou
Rafiou Adamou
CDCélia Dechavanne
Célia Dechavanne
ISIbrahim Sadissou
Ibrahim Sadissou
TDTania D’aLmeida
Tania D’aLmeida
ABAziz Bouraima
Aziz Bouraima
DCDavid Courtin
David Courtin
Substantial evidence indicates that cytophilic IgG responses to Plasmodium falciparum merozoite antigens play a role in protection from malaria. The specific targets mediating immunity remain unclear. Evaluating antibody responses in infants naturally-exposed to malaria will allow to better understand the establishment of anti-malarial immunity and to contribute to a vaccine development by identifying the most appropriate merozoite candidate antigens. The study was based on parasitological and clinical active follow-up of infants from birth to 18 months of age conducted in the Tori Bossito area of southern Benin. For 399 infants, plasma levels of cytophilic IgG antibodies with specificity for five asexual stage malaria vaccine candidate antigens were determined by ELISA in infants’ peripheral blood at 6, 9, 12 and 15 months of age. Multivariate mixed logistic model was used to investigate the association between antibody levels and anti-malarial protection in the trimester following the IgG quantification. Moreover, the concentrations of merozoite antigen-specific IgG were compared between a group of infants apparently able to control asymptomatic malaria infection (CAIG) and a group of infants with no control of malaria infection (Control group (NCIG)). Protective effect of antibodies was also assessed after 15 months of malaria exposure with a Cox regression model adjusted on environmental risk. Cytophilic IgG responses to AMA1, MSP1, MSP2-3D7, MSP2-FC27, MSP3 and GLURP R2 were associated with increasing malarial infection risk in univariate analysis. The multivariate mixed model showed that IgG1 and IgG3 to AMA1 were associated with an increased risk of malarial infection. However infants from CAIG (n = 53) had significantly higher AMA1-, MSP2-FC27-, MSP3-specific IgG1 and AMA1-, MSP1-, MSP2-FC27-, MSP3 and GLURP-R2-specific IgG3 than those from NCIG (n = 183). The latter IgG responses were not associated with protection against clinical malaria in the whole cohort when protective effect is assessed after 15 months of malaria exposition. In this cohort, merozoite antigen-specific cytophilic IgG levels represent a marker of malaria exposure in infants from 6 to 18 months of age. However, infants with resolution of asymptomatic infection (CAIG) seem to have acquired naturally immunity against P. falciparum. This observation is encouraging in the context of the development of multitarget P. falciparum vaccines.

4 February 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CVCharlotte VOISIN
Charlotte VOISIN
GCGhislaine Cauchois
Ghislaine Cauchois
LRLoïc Reppel
Loïc Reppel
CLCaroline Laroye
Caroline Laroye
LLLaetitia Louarn
Laetitia Louarn
CHCéline Huselstein
Céline Huselstein
Background: Umbilical mesenchymal stem/stromal cells (MSCs), and especially those derived from Wharton’s jelly (WJ), are a promising engineering tool for tissue repair in an allogeneic context. This is due to their differentiation capacity and immunological properties, like their immunomodulatory potential and paracrine activity. Hence, these cells may be considered an Advanced Therapy Medicinal Product (ATMP). The purpose of this work was to differentiate MSCs from WJ (WJ-MSCs) into chondrocytes using a scaffold and to evaluate, in vitro, the immunomodulatory capacities of WJ-MSCs in an allogeneic and inflammatory context, mimicked by IFN-γ and TNF-α priming during the chondrogenic differentiation. Methods: Scaffolds were made from hydrogel composed by alginate enriched in hyaluronic acid (Alg/HA). Chondrogenic differentiation, immunological function, phenotype expression, but also secreted soluble factors were the different parameters followed during 28 days of culture. Results: During chondrocyte differentiation, even in an allogeneic context, WJ-MSCs remained unable to establish the immunological synapse or to induce T cell alloproliferation. Moreover, interestingly, paracrine activity and functional immunomodulation were maintained during cell differentiation. Conclusion: These results show that WJ-MSCs remained hypoimmunogenic and retained immunomodulatory properties even when they had undergone chondrocyte differentiation.

1 December 2018 in Molecular Immunology
Verified
Journal Article
Closed access
PSPaulin Sonon
Paulin Sonon
ISIbrahim Sadissou
Ibrahim Sadissou
LTLéonidas Tokplonou
Léonidas Tokplonou
KMKuumaaté K.G. M'PO
Kuumaaté K.G. M'PO
SGSonya S.C. Glitho
Sonya S.C. Glitho
EDEduardo A. Donadi
Eduardo A. Donadi

5 February 2020 in Parasite Immunology
Verified
Journal Article
Closed access
PDF file
LTLéonidas Tokplonou
Léonidas Tokplonou
ONOdilon Nouatin
Odilon Nouatin
PSPaulin Sonon
Paulin Sonon
GMGrace M’pO
Grace M’pO
SGSonya Glitho
Sonya Glitho
DCDavid Courtin
David Courtin

30 October 2019 in Human Genetics
Verified
Journal Article
Closed access
PDF file
JMJacqueline Milet
Jacqueline Milet
ABAnne Boland
Anne Boland
PLPierre Luisi
Pierre Luisi
ASAudrey Sabbagh
Audrey Sabbagh
ISIbrahim Sadissou
Ibrahim Sadissou
HPHervé Perdry
Hervé Perdry